Skip to content

Reconstructive Treatment of Peri-implantitis With Electrolytic Decontamination Versus Titanium Brushes

Reconstructive Treatment of Peri-implantitis With Electrolytic Decontamination Versus Titanium Brushes: a Randomized Controlled Trial

Status
Not yet recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07814391
Acronym
Galvo vs mech
Enrollment
38
Registered
2026-09-11
Start date
2027-01-01
Completion date
2027-04-01
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri-Implantitis and Peri-implant Mucositis

Keywords

electrolytic cleaning, reconstructive treatment, demineralized bovine bone mineral (DBBM), titanium brush

Brief summary

Implants diagnosed with peri-implantitis and amenable for bone reconstructive treatment will be enrolled in the study. The implants will randomly be treated with either an electrolytic or a mechanical cleaning of the implant surface (with titanium brushes). In all cases, a bone graft will be used to rebuild missing bone.

Detailed description

Implants diagnosed with peri-implantitis and amenable for bone reconstructive treatment will be enrolled in the study. All implants will receive reconstructive therapy by means of a collagenated bone graft, however the method of decontamination will be randomized between electrolytic cleaning or titanium rotating brushes. In both cases, titanium curettes will be used to remove hard deposits on the implant surface and degranulation will be completed with curettes.

Interventions

PROCEDUREtest device GalvoSurge

Electrolytic decontamination

PROCEDUREMechanical decontamination with titanium brush

Reconstructive treatment of peri-implantitis after removal of hard and soft tissue deposits from the implant surface followed by mechanical decontamination with titanium brush

Sponsors

George Eastman Dental Hospital, Italy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Implants with peri-implantitis (defined according to 2017 World Workshop definitions) * contained defects with infra osseous component amenable to reconstructive treatment * fixed and removable superstructures * patients with no systemic conditions affecting healing (uncontrolled diabetes mellitus, chronic corticosteroid use, autoimmune conditions affecting connective tissue) * smoking more than 10 cigarettes

Exclusion criteria

* mobile implants * non removable crowns (both cement or screw retained) that cannot be removed prior to surgery

Design outcomes

Primary

MeasureTime frameDescription
Change in Probing pocket depthfrom baseline to 12, 24 months post-surgerydistance (mm) between marginal mucosa and bottom of probable pocket

Secondary

MeasureTime frameDescription
change in recessionbaseline to 12 and 24 months post-opchange between baseline and 24 months (mm)
change in CALbetween baseline and 24 monthschange in CAL between baseline and 24 months (mm)
Suppuration on probing (SoP)baseline, 12, 24 monthsDichotomic variable
Bleeding on probingbaseline, 12, 24 monthsDichotomic variable (yes/ no)
Keratinized mucosa (KM)baseline, 12, 24 monthscontinuous, measured in mm, from the margin of the mucosa to the mucogingival junction
Treatment Success24 monthsComposite outcome comprising implant not lost, no more than 1 mm of buccal recession, no more than 5 mm of PPD, no SOP, no more than 1 bleeding spot on probing, no loss of crestal bone (mm)

Contacts

CONTACTLucrezia Paterno Holtzman, DDS, MS
lucreziaph@gmail.com+393398035371
CONTACTLuca Cordaro, DDS MD
lucacordaro@usa.net

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026